IPAD-DB ID | S01227 |
Name | 6-chlorotacrine(Cl-THA) |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 3 H 1 3 C l N 2 |
Molecular Weight | 232.71 g/mol |
IUPAC Name | 6-chloro-1, 2, 3, 4-tetrahydroacridin-9-amine |
InChI | InChI=1S/C13H13ClN2/c14-8-5-6-10-12(7-8)16-11-4-2-1-3-9(11)13(10)15/h5-7H, 1-4H2, (H2, 15, 16) |
InChIKey | GQZMDBQRGRRPMS-UHFFFAOYSA-N |
Canonical SMILES | C1CCC2=NC3=C(C=CC(=C3)Cl)C(=C2C1)N |
PubChem CID | 10399068 |
DrugBank Accession Number | - |
CAS Registry Number | 5778-84-7 |
Molecular Weight(Computed by SwissADME) | 232.71 |
Hac(Computed by SwissADME) | 16 |
Volume(Computed by ADMETlab 2.0) | 231.757 |
Density(Computed by ADMETlab 2.0) | 1.001 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 14 |
nHet(Computed by ADMETlab 2.0) | 3 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 17 |
Flexibility(Computed by ADMETlab 2.0) | 0 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.174 |
LogD(Computed by ADMETlab 2.0) | 3.13 |
logP(Computed by ADMETlab 2.0) | 3.69 |
TPSA(Computed by SwissADME) | 38.91 |
Hbond Acceptor(Computed by SwissADME) | 1 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) | 0 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.35 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |